Skip to Main Content

Cultural Ambassadors

A Unique Community Partnership

YCCI recognizes that broadening community participation in clinical research involves linking investigators directly to resources in the community.

Cultural ambassadors are available to:

  • Participate in projects, community engagement activities and community events designed to promote and increase participation in clinical trials.
  • Assist in the development of recruitment plans for specific trials.
  • Assist in the development of protocols for specific trials.
  • Provide translation services for informed consents and other materials into Spanish.

YCCI initially provided intensive training on topics such as the importance of clinical research, how it is conducted, and protections for human subjects. Continuing education is provided on an ongoing basis through monthly faculty presentations.

For more information or to request services provided by this program, please contact Brittany Harris at 203.785.2504 or brittany.harris@yale.edu.

The African Methodist Episcopal (AME) Zion Church, the nation’s oldest denomination, is a major faith-based organization servicing more than 1,000,000 members.
Junta for Progressive Action, Inc. is partnering with Yale to raise awareness in the Latino community regarding clinical research and its role in addressing health disparities.

Yale, Community partners and the FDA Office of Minority Health and Health Equity

Yale, our community partners, and the FDA Office of Minority Health and Health Equity are catalyzing racial equity in clinical trials through community empowerment. For more than a decade under the CTSA, the Yale Center for Clinical Investigation and our Cultural Ambassadors have focused on addressing diverse participation in clinical trials and bridging health gaps. In partnership with the FDA Office of Minority Health and Health Equity, we are connecting investigators to our community and patients—the heroes of clinical research—as one of the hallmarks of YCCI.  Learn more about Yale's program, the FDA and minority health, and the importance of participating in clinical trials for all populations.

Watch video